Tenzing MEMO publishes independent research you won't find anywhere else. Sign up for a free trial to access everything — including 29 articles published in the last two weeks.
On cash flow, this stock is already struck closer to a mid-cycle oil deck than to the futures strip, and the next twelve months of return comes out of the balance sheet rather than out of the multiple.
The market is still pricing Devon as though 40% of its barrels will go on earning 2% of its revenue, and that is the one thing about this company that is already changing
The market has marked down a franchise for a threat it cannot yet feel, and at 37 times forward earnings Howmet is worth owning — not for a re-rating to $328, but because the business is compounding faster than the multiple needs to expand.
At 16x guided 2026 adjusted operating profit and 34x the guided cash floor, with clean margin lower than a year ago and the 2027 step resting on suppliers, Embraer's equity is fully valued — a franchise worth owning at a price the market is no longer offering.
Matador's reported earnings and its cash earnings have been separated by a contract with a termination date, and the market has been pricing the former.
The bull case needs nothing new — only that a brand posting 17% growth in its own channels, with inventory down 5% and a raised earnings guide, is not the brand that gets caught in someone else's clearance event.
The company is a fixed-fee volume engine that beat on reliability, is forward-sold through year-end, has a funded ramp to 60–63 MTPA nearly complete, and is retiring roughly 3% of its shares a year.
The harder, less-discussed truth about BridgeBio is that the equity sitting on top of this franchise is a thin residual behind a capital structure that private-credit and private-equity sponsors engineered to harvest the ramp first.
This is not a company watching solar demand evaporate; it is a premium hardware franchise re-routing US demand from cash sales onto TPO rails while monetizing a domestic-manufacturing credit annuity that peers can't match. The three things that decide the next two quarters are...
The market is trading this as a comp-recovery story, and the comp has recovered, but the actual swing factor for the next leg of the stock is margin, and specifically North America margin, which is still badly depressed.